Viral infection in induction of Hashimoto's thyroiditis: A key player or just a bystander?

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 17, Issue 5, 2010, Pages 418-424

  Mori, Kouki ^a   Yoshida, Katsumi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hashimoto's thyroiditis; innate immunity; viral infection

Indexed keywords

ALPHA INTERFERON; FC RECEPTOR; THYROID HORMONE; TOLL LIKE RECEPTOR;

ANTIGEN PRESENTING CELL; AUTOIMMUNE THYROIDITIS; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL INFILTRATION; DIABETES MELLITUS; GENETIC POLYMORPHISM; HAPLOTYPE; HASHIMOTO DISEASE; HEPATITIS C; HEPATITIS C VIRUS; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; VIRUS INFECTION;

ANIMALS; FEMALE; HASHIMOTO DISEASE; HUMANS; HYGIENE; INTESTINES; MICE; RATS; RECEPTORS, IGG; T-LYMPHOCYTES; THYROID GLAND; TOLL-LIKE RECEPTORS; VIRUS DISEASES; VIRUSES;

EID: 77956267713     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e32833cf518     Document Type: Review

References (122)

1. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160:526-534.
2. Champion BR, Cooke A, Rayner DC. Thyroid autoimmunity. Curr Opin Immunol 1992; 4:770-778.
3. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996; 335:99-107.
4. Paschke R, Schuppert F, Taton M, Velu T. Intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis. J Endocrinol 1994; 141:309-315.
5. Tomer Y, Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 2009; 32:231-239.
6. Brix TH, Kyvik KO, Hegedus L A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 2000; 85:536-539.
7. Bach J-F. Infections and autoimmune diseases. J Autoimmun 2005; 25:74-80.
8. Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocr Rev 1993; 14:107-120.
9. Prummel MF, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases. Eur J Endocrinol 2004; 150:605-618.
10. Krassas GE, Tziomalos K, Pontikides N, et al. Seasonality of month of birth of patients with Graves' and Hashimoto's diseases differ from that in the general population. Eur J Endocrinol 2007; 156:631-636.
11. Valtonen VV, Ruutu P, Varis K, et al. Serological evidence for the role of bacterial infections in the pathogenesis of thyroid diseases. Acta Med Scand 1986; 219:105-111.
12. Desailloud R, Hober D. Viruses and thyroiditis: an update. Virology J 2009; 6:5-18.
13. Honeyman M. How robust is the evidence for viruses in the induction of type 1 diabetes. Curr Opin Immunol 2005; 17:616-623.
14. Chervonsky A. Innate receptors and microbes in induction of autoimmunity. Curr Opin Immunol 2009; 21:641-647.
15. Antonelli A, Ferri C, Ferrari SM, et al. Endocrine manifestations of hepatitis C virus infection. Nat Clin Pract Endocrinol Metab 2009; 5:26-34.
16. Tomer Y. Hepatitis C and interferon induced thyroiditis. J Autoimmun 2010; 43J322-J326.
17. Antonelli A, Ferri C, Pampana A, et al. Thyroid disorders in chronic hepatitis C. Am J Med 2004; 117:10-13.
18. Testa A, Castaldi P, Fant V, et al. Prevalence of HCV antibodies in autoimmune thyroid disease. Eur Rev Med Pharmacol Sci 2006; 10:183-186.
19. Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, et al. Increased risk of autoimmune thyroid disease in hepatitis Cvs. hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med 1998; 158:1445-1448.
20. Maya R, Gershwin MC, Shoenfeld Y. Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allegy Immunol 2008; 34:85-102.
21. Melo FM, Vasconcelos LRS, Silva BS, et al. Structural polymorphism of the mannose-binding lectin 2 (MBL2) gene in HCV-infected patients with a serological marker for thyroid autoimmunity. Int J Immunogenet 2009; 36:377-381.
22. Martocchia A, Falaschi P. Amino acid sequence homologies between HCV polyprotein and thyroid antigens. Intern Emerg Med 2007; 2:65-67.
23. + fluorescent mouse. Clin Immunol 2006; 121:108-117.
24. Bartolome J, Rodŕ?guez-Iñgo E, Quadros P, et al. Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection. J Med Virol 2008; 80:1588-1594.
25. Akeno N, Blackard JT, Tomer Y. HCVE2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J Autoimmun 2008; 31:339-344.
26. Antonelli A, Ferri C, Fallahi P, et al. High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis. Cytokine 2008; 42:137-143.
27. Carella C, Mazziotti G, Amato G, et al. Interferon-a-related thyroid disease: pathophysiological, epidemiological, and clinical aspects. J Clin Endocrinol Metab 2004; 89:3656-3661.
28. Kerr JR. Parvovirus B19 infection. Eur J Clin Microbiol Infect Dis 1996; 15:10-29.
29. Murai C, Munakata Y, Takahashi Y, et al. Rheumatoid arthritis after human parvovirus B19 infection. Ann Rheum Dis 1999; 58:130-132.
30. Takahashi Y, Murai C, Shibata S, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA 1998; 95:8227-8232.
31. Mori K, Munakata Y, Saito T, et al. Intrathyroidal persistence of human parvovirus B19 DNA in a patient with Hashimoto's thyroiditis. J Infect 2007; 55:e29-e31.
32. Lehmann HW, Lutterbuse N, Plentz A, et al. Association of parvovirus B19 infection and Hashimoto's thyroiditis in children. Viral Immunol 2008; 21:379-383.
33. Wang J, Zhang W, Liu H, et al. Parvovirus B19 infection associated with Hashimoto's thyroiditis in adults. J Infect 2010; 60:360-370.
34. Takasawa N, Munakata Y, Kumura-Ishii K, et al. Human parvovirus B19 transgenic mice become susceptible to polyarthritis. J Immunol 2004; 173:4675-4683.
35. Mori K, Yoshida Y, Ishii K, et al. Experimental autoimmune thyroiditis in human parvovirus B19 transgenic mice. Program of the 9th Asia-Oceania Thyroid Congress 2009, p 95, Nagoya, Japan.
36. Haverkos HW, Battula N, Drotman DP, Rennert OM. Enteroviruses and type 1 diabetes mellitus. Biomed Pharmacother 2003; 57:379-385.
37. Bernard NF, Ertug F, Margolese H. High incidence of thyroiditis and antithyroid autoantibodies in NOD mice. Diabetes 1991; 41:40-46.
38. Serreze DV, Ottendorfer EW, Ellis TM, et al. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreas islets. Diabetes 2000; 49:708-711.
39. Svensson J, Lindberg B, Jonsson B, et al. Intrauterine exposure to maternal enterovirus infection as a risk factor for development of autoimmune thyroiditis during childhood and adolescence. Thyroid 2004; 14:367-370.
40. Desailloud R, Goffard A, Page C, et al. Detection of enterovirus RNA in postoperative thyroid tissue specimens. Clin Endocrinol 2009; 70:331-334.
41. Thomas D, Karachaliou F, Kallergi K, et al. Herpes virus antibodies seropre-valence in children with autoimmune thyroid disease. Endocr 2008; 33:171-175.
42. Leite JL, Bufalo NE, Santos RB, et al. Herpesvirus type 7 infection may play an important role in individuals with a genetic profile of susceptibility to Graves' disease. Eur J Endocrinol 2010; 162:315-321.
43. Thomas D, Liakos V, Michou V, et al. Detection of herpes virus DNA in postoperative thyroid tissue specimens of patients with autoimmune thyroid disease. Exp Clin Endocrinol Metab 2008; 116:35-39.
44. Burek CL, Taylor MV. Environmental triggers and autoimmune thyroiditis.J Autoimmun 2009; 33:183-189.
45. Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity: friends or foes? Trends Immunol 2009; 30:409-414.
46. Wolter TR, Wong R, Sarker SA, Zipris D. DNA microarray analysis for the identification of innate immune pathways implicated in virus-induced auto immune diabetes. Clin Immunol 2009; 132:103-115.
47. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol 2006; 117:979-987.
48. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kB by Toll-like receptor 3. Nature 2001; 413:732-738.
49. Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 2004; 303:1526-1529.
50. Hemmi H,Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740-745.
51. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999; 11:443-451.
52. Manetti R, Annunziato F, Tomasevic L, et al. Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-a and interleukin-12. Eur J Immunol 1995; 25:2656-2660.
53. Chu RS, Targoni OS, Kreig AM, et al. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 1997; 186:1623-1631.
54. Redecke V, Hacker H, Datta SK, et al. Activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004; 172:2739-2743.
55. Sutmuller RPM, den Brok MHMGM, Kramer M, et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006; 116:485-494.
56. Liu H, Komai-Koma M, Xu D, Liew FY. Toll-like receptor 2 signaling modulates the functions of CD4+CD25+ regulatory T cells. Proc Natl Acad Sci USA 2006; 103:7048-7053.
57. Moseman EA, Liang X, Dawson AJ, et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol 2004; 173:4433-4442.
58. LaRosa DF, Gelman AE, Rahman AH, et al. CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependentcostimulation of effector CD4+ T cells. Immunol Lett 2007; 108:183-188.
59. Li M, Zhou Y, Feng G, Su SB. The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases. Curr Mol Med 2009; 9:365-374.
60. Lien E, Zipris D. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes. Curr Mol Med 2009; 9:52-68.
61. Devaraj S, Dasu MR, Rockwood J, et al. Increased Toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type I diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008; 93:578-583.
62. Pirie FJ, Pegoraro R, Motala AA, et al. Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes. Tissue Antigens 2005; 66:125-130.
63. Ewel CH,Sobel DO, Zeligs BJ, Bellanti JA. Poly I:Caccelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes 1992; 41:1016-1021.
64. Zipris D, Lien E, Xie JX, et al. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J Immunol 2005; 174:131-142.
65. Zipris D, Lien E, Nair A, et al. TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the BioBreeding diabetes-resistant rat. J Immunol 2007; 178:693-701.
66. Serreze DV, Hamaguchi K, Leiter EH. Immunostimulation circumvents diabetes in NOD/Lt mice. J Autoimmun 1989; 2:759-776.
67. Quintana FJ, Rotem A, Carmi P, Cohen IR. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein in autoimmunity. J Immunol 2000; 165:6148-6155.
68. Kim HS, Han MS, Chung KW, et al. Toll-like receptor 2 senses fi-cell death and contributes to the initiation of autoimmune diabetes. Immunity 2007; 27:321-333.
69. Wen L, Ley RE, Volchkov PV, et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 2008; 455:1109-1113.
70. Abdollahi-Roodsaz S, Joosten LAB, Koenders MI, et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008; 118:205-216.
71. Harii N, Lewis CJ, Vasko V, et al. Thyrocytes express a functional Toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis. Mol Endocrinol 2005; 19:1231-1250.
72. Nicola JP, Velez ML, Lucero AM, et al. Functional Toll-like receptor 4 conferring lipopolysaccharide responsiveness is expressed in thyroid cells. Endocrinology 2009; 150:500-508.
73. Morohoshi K, Mori K, Nakagawa Y, et al. Toll-like receptor activation fails to induce lymphocytic thyroiditis in nonobese diabetic mice. Endocr J 2010; 57 (Suppl. 2):S478.
74. Takai T. Fc receptors and their role in immune regulation and autoimmunity. J Clin Immunol 2005; 25:1-18.
75. Forthal DN, Moog C. Fc receptor-mediated antiviral antibodies. Curr Opin HIV AIDS 2009; 4:388-393.
76. Yajima K, Nakamura A, Sugahara A, Takai T. Fc7RIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease. Eur J Immunol 2003; 33:1020-1029.
77. Pritchard NR, Cutler AJ, Uribe S, et al. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor Fc7RII. Curr Biol 2000; 10:227-230.
78. Jiang Y, Hirose S, Abe M, et al. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunoge-netics 2000; 51:429-435.
79. Kyogoku C, Dijstelbloem HM, Tsuchiya N, et al. Fc7 receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 2002; 46:1242-1254.
80. Kleinau S, Martinsson P, Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct Fc7 receptors. J Exp Med 2000; 191:1611-1616.
81. Inoue Y, Kaifu T, Sugahara-Tobinai A, et al. Activating Fc7 receptors participate in the development of autoimmune diabetes in NOD mice. J Immunol 2007; 179:764-774.
82. Ozaki H, Mori K, Inoue Y, et al. Autoimmune thyroiditis in Fc7 receptordeficient nonobese diabetic mice. Clin Immunol 2009; 132:291-293.
83. Gavin AL, Tan PS, Hogarth PM. Gain-of-function mutations in Fc7RI of NOD mice: implications for the evolution of the Ig superfamily. EMBO J 1998; 17:3850-3857.
84. Luan JJ, Monteiro RC, Sautes C, et al. Defective Fc7RII gene expression in macrophages of NOD mice. Genetic linkage with up-regulation of IgG1 and IgG2b in serum. J Immunol 1996; 157:4707-4716.
85. Kimura T, Nakayama K, Nagaya T, et al. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 1994; 264:1921-1924.
86. Matsuyama T, Kimura T, Kitagawa M, et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type IIFN gene induction and aberrant lymphocyte development. Cell 1993; 75:83-97.
87. + thymocytes. Immunity 1997; 7:243-254.
88. Lohoff M, Ferrick D, Mittrucker H-W, et al. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 1997; 6:681-689.
89. Suzuki K, Mori A, Ishii K, et al. Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci USA 1999; 96:2285-2290.
90. Mori K, Stone S, Khaodhiar L, et al. Induction of transcription factor interferon regulatory factor-1 by interferon-7 (IFN7) and tumor necrosis factor-a (TNFa) in FRTL-5 cells. J Cell Biochem 1999; 74:211-219.
91. Tani J-I, Mori K, Hoshikawa S, et al. Prevention of lymphocytic thyroiditis in iodide-treated nonobese diabetic mice lacking interferon regulatory factor-1. Eur J Endocrinol 2002; 147:809-814.
92. Jin Z, Mori K, Fujimori K, et al. Experimental autoimmune thyroiditis in nonobese diabetic mice lacking interferon regulatory factor-1. Clin Immunol 2004; 113:187-192.
93. Tada Y, Ho A, Matsuyama T, Mak TW. Reduced incidence and severity of antigen-induced autoimmune disease in mice lacking interferon regulatory factor-1. J Exp Med 1997; 185:231-238.
94. Nakazawa T, Satoh J, Takahashi K, et al. Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1. J Autoimmun 2001; 17:119-125.
95. Der SD, Lau AS. Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. Proc Natl Acad Sci USA 1995; 92:8841-8845.
96. Mori K, Yoshida K, Tani J-I, et al. Double-stranded RNA-induced interferon regulatory factor-1 gene expression in FRTL-5 rat thyroid cells. Mol Cell Endocrinol 2001; 184:77-86.
97. Magnusson M,Zare F, Tarkowski A. Requirement of type I interferon signaling for arthritis triggered by double-stranded RNA. Arthritis Rheum 2006; 54:148-157.
98. Fallarino F, Volpi C, Zelante T, et al. IDO mediates TLR9-driven protection from experimental autoimmune diabetes. J Immunol 2009; 183:6303-6312.
99. h4 mice from developing autoimmune thyroiditis. Endocrinology 2009; 150:1545-1551.
100. Lin H-Y, Thacore HR, Davis PJ, Davis FB. Thyroid hormone potentiates the antiviral action of interferon-7 in cultured human cells. J Clin Endocrinol Metab 1994; 79:62-65.
101. Lin H-Y, Martino LJ, Wilcox BD, et al. Potentiation by thyroid hormone of human IFN-7-induced HLA-DR expression. J Immunol 1998; 161:843-849.
102. Gale EAM. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002; 51:3353-3361.
103. Gibbon C, Smith T, Egger P, et al. Early infection and subsequent insulin dependent diabetes. Arch Dis Child 1997; 77:384-385.
104. McKinney PA, Okasha M, Parslow RC, et al. Early social mixing and childhood type 1 diabetes mellitus: a case-control study in Yorkshire, UK. Diabet Med 2000; 17:236-242.
105. Bloomfield SF, Stanwell-Smith R, Crevel RWR, Pickup J. Too clean, or not too clean: the hygiene hypothesis and home hygiene. Clin Exp Allergy 2006; 36:402-425.
106. Kondrashova A, Viskari H, Haapala A-M, et al. Serological evidence of thyroid autoimmunity among schoolchildren in two different socioeconomic environments. J Clin Endocrinol Metab 2008; 93:729-734.
107. Strachan DP. Hay fever, hygiene, and household size. Br Med J 1989; 299:1259-1260.
108. Oldstone MBA. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 1988; 239:500-502.
109. Like AA, Guberski DL, Butler L. Influence of environmental viral agents on frequency and tempo of diabetes mellitus in BB/Wor rats. Diabetes 1991; 40:259-262.
110. Breban MA, Moreau MC, Fournier C, et al. Influence of the bacterial flora on collagen-induced arthritis in susceptible and resistant strains of rats. Clin Exp Rheumatol 1993; 11:61-64.
111. Filippi CM, Estes EA, Oldham JE, von Herrath MG. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J Clin Invest 2009; 119:1515-1523.
112. Penhale WJ, Young PR. The influence of the normal microbial flora on the susceptibility of rats to experimental autoimmune thyroiditis. Clin Exp Immunol 1988; 72:288-292.
113. Kalliomäki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107:129-134.
114. Droste JHJ, Wieringa MH, Weyler JJ, et al. Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease? Clin Exp Allergy 2000; 30:1547-1553.
115. H2-dominany immunity in mice. J Allergy Clin Immunol 2001; 107:153-159.
116. Pessi T, Sü tas Y, Hurme M, Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 2000; 30:1804-1808.
117. Kalliomäki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001; 357:1076-1079.
118. Bouskra D, Bré zillon C, Bérard M, et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 2008; 456:507-510.
119. Iwata M, Hirakiyama A, Eshima Y, et al. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004; 21:527-538.
120. h2 development via retinoic acid receptors. Int Immunol 2003; 15:1017-1025.
121. Muchida D, Park Y, Kim G, et al. Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317:256-260.
122. Van Y-H, Lee W-H, Ortiz S, et al. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-g-producing T-cells without affecting Th17 cells. Diabetes 2009; 58:146-155.